BGAI
WST icon

Bruce G. Allen Investments’s West Pharmaceutical WST Stock Holding History

Bruce G. Allen Investments’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$718 Hold
2
– – ﹤0.01% 875
2026
Q1 		$501 Hold
2
– – ﹤0.01% 969
2025
Q4 		$550 Hold
2
– – ﹤0.01% 955
2025
Q3 		$525 Hold
2
– – ﹤0.01% 960
2025
Q2 		$438 Sell
2
-3
-60% -$641 ﹤0.01% 976
2025
Q1 		$1.12K Buy
+5
New +$1.38K ﹤0.01% 785

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Bruce G. Allen Investments's WST Position: Q2 2026 in Review

Bruce G. Allen Investments held its West Pharmaceutical (WST) position steady in Q2 2026 at 2 shares worth $718. The position accounts for ﹤0.01% of the portfolio, ranked #875.

Bruce G. Allen Investments first reported a position in WST in Q1 2025 and has held it in 6 quarters since. The position peaked at $1.12K in Q1 2025. 834 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Bruce G. Allen Investments held 2 shares of West Pharmaceutical worth $718 as of Q2 2026.
  • Bruce G. Allen Investments left its West Pharmaceutical share count unchanged in Q2 2026.
  • West Pharmaceutical made up ﹤0.01% of Bruce G. Allen Investments's portfolio in Q2 2026, its #875 holding.
  • Bruce G. Allen Investments first reported a position in West Pharmaceutical in Q1 2025 and has held it in 6 quarters since.
  • Bruce G. Allen Investments's West Pharmaceutical position peaked at $1.12K in Q1 2025.
  • 834 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Bruce G. Allen Investments's 13F filing for Q2 2026, filed 31 Jul 2026.